Point-of-Care Glucose Testing Market Growth, Size, Trends Analysis - By Product - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Point-of-Care Glucose Testing Market Introduction and Overview

According to SPER market research, ‘Global Point-of-Care Glucose Testing Market Size- By Product – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Point-of-Care Glucose Testing Market is predicted to reach 5.36 Billion by 2034 with a CAGR 4.39%.

Point-of-care glucose testing allows for immediate blood sugar measurement at the patient’s location, rather than requiring lab analysis. This method is essential for diabetes management, a condition affecting blood glucose regulation. The testing process utilizes tools like test strips, lancets, lancing devices, and glucose meters. Rising awareness of diabetes management, limited access to healthcare, the scarcity of healthcare workers, and the highest prevalence of diabetes recorded in Asian countries are likely to increase the use of POC glucose testing solutions.

Restraints:Strict regulatory approvals, necessary for safety and accuracy, create hurdles for point-of-care diagnostic product commercialization. These rigorous processes, including testing and trials mandated by bodies like the FDA and CE marking, result in delayed market entry, high development costs, and challenges for smaller businesses.

Scope of the Report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments coveredBy Product.

Regions covered:
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered
Abbott, Bayer AG/Ascensia Diabetes Care Holdings AG, EKF Diagnostics, F. Hoffmann-La Roche Ltd., Nipro, Nova Biomedical, PlatInium Equity Advisors, LLC (Lifescan, Inc.), Prodigy Diabetes Care, LLC, and Trividia Health, Inc. and others.

Point-of-Care Glucose Testing Market Segmentation:

By Product:Based on the Product, Global Point-of-Care Glucose Testing Market is segmented as; Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer CONTOUR Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip, Other.

By Region:This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.